Hepatitis C treatment study
Treatments studied
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests a pill combination (sofosbuvir/velpatasvir) to cure hepatitis C. It aims to make treatment simple and accessible, and you can join even if you've had treatment before (if it failed or you got reinfected).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 16 years old.
- You need to be willing to get tested for HIV, hepatitis B, and hepatitis C.
- You must be willing to take hepatitis C medication and follow the study schedule.
- You should not have already been treated for your current hepatitis C infection (unless it didn't work or you got infected again after treatment).
- You must not have severe liver damage (like cirrhosis with complications).
- You should not be on a daily high-dose heartburn pill, or be willing to reduce the dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
This study offers a one-stop approach to testing and treating hepatitis C during a single emergency room visit. If you test positive, you may receive treatment right away, potentially avoiding extra appointments and helping you get cured faster.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This trial tests whether a very short 4-week course of two hepatitis C drugs (sofosbuvir and glecaprevir-pibrentasvir) can cure hepatitis C in people with early-stage liver disease. The goal is to see if a shorter treatment works as well as longer ones.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This trial compares a simplified way of testing and treating hepatitis C with the standard approach. It aims to see if the simpler method works just as well and makes it easier for people to get treated.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.